Statistics for Mechanisms of Resistance to First-Line Osimertinib in Hispanic Patients With EGFR Mutant Non-Small Cell Lung Cancer (FRESTON-CLICaP)

Total visits

views
Mechanisms of Resistance to First-Line Osimertinib in Hispanic Patients With EGFR Mutant Non-Small Cell Lung Cancer (FRESTON-CLICaP) 0

Total visits per month

views
September 2025 0
October 2025 0
November 2025 0
December 2025 0
January 2026 0
February 2026 0
March 2026 0